Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Case Rep ; 12(1): 86, 2018 Mar 30.
Article in English | MEDLINE | ID: mdl-29602306

ABSTRACT

BACKGROUND: Coronary artery fistula, first described by Krause in 1865, is an abnormal communication between the coronary artery and one of the four chambers of the heart or one of the great vessels. The communications are often congenital but may also be acquired from trauma or invasive cardiovascular procedures. Half of the cases present with angina pectoris whereas the remaining half are incidentally detected on echocardiogram or angiogram performed for an unrelated reason. Takotsubo cardiomyopathy or stress-induced cardiomyopathy is characterized by transient left ventricular dysfunction with minimal elevation of cardiac biomarkers in the absence of underlying coronary artery disease. Almost 90% of reported patients are postmenopausal women with a history of recent emotional or physical stress. CASE PRESENTATION: We report an unusual case of a 64-year-old Hispanic woman presenting with typical symptoms suggestive of acute coronary syndrome after an extreme familial conflict. There was mild troponin elevation. Cardiac catheterization revealed microfistulas originating from the third portion of the left anterior descending artery draining to the left ventricular cavity. The ventriculogram demonstrated the apical ballooning. We postulate that high local concentration of catecholamine triggered by stress resulted in angina pectoris due to worsening coronary steal from the coronary fistula. Also, the stress-induced adrenergic stimulation unmasked the classical akinetic apex and apical ballooning characteristic of Takotsubo cardiomyopathy. CONCLUSIONS: This case report highlights the rare but important association between two uncommon conditions. To the best of our knowledge, only one similar case has been reported describing a patient with microfistulas to left ventricular cavity and concurrent Takotsubo cardiomyopathy.


Subject(s)
Coronary Vessels/pathology , Takotsubo Cardiomyopathy/complications , Vascular Fistula/complications , Angina Pectoris/diagnosis , Angina Pectoris/etiology , Angina Pectoris/physiopathology , Anti-Arrhythmia Agents/therapeutic use , Aspirin/therapeutic use , Cardiac Catheterization/methods , Catecholamines/metabolism , Chest Pain , Coronary Angiography , Echocardiography , Female , Humans , Metoprolol/therapeutic use , Middle Aged , Platelet Aggregation Inhibitors/therapeutic use , Takotsubo Cardiomyopathy/diagnosis , Takotsubo Cardiomyopathy/physiopathology , Takotsubo Cardiomyopathy/therapy , Treatment Outcome , Vascular Fistula/diagnosis , Vascular Fistula/pathology , Vascular Fistula/therapy
2.
J Med Case Rep ; 11(1): 17, 2017 Jan 18.
Article in English | MEDLINE | ID: mdl-28095921

ABSTRACT

BACKGROUND: Papillary fibroelastomas are rare, benign cardiac tumors that are often found on cardiac valvular surfaces. Most are incidental discoveries during surgery or autopsy. The clinical presentation of fibroelastoma varies widely, ranging from clinically asymptomatic to severe thromboembolic events. CASE PRESENTATION: We report a case of 65-year-old white man diagnosed with scattered, bilateral acute cerebral hemisphere infarcts with a history of chronic angina. Transesophageal echocardiography identified a fibroelastoma on the right coronary cusp of the aortic leaflet. Cardiac catheterization revealed mild non-obstructive stenosis. We postulate that the etiology of his angina is related to the dynamic occlusion of his right coronary ostium by the fibroelastoma. CONCLUSIONS: To the best of our knowledge, this is the first case report describing a patient with a cardiac papillary fibroelastoma who presented with both chronic angina and acute stroke.


Subject(s)
Angina, Stable/etiology , Aortic Valve , Fibroma/complications , Heart Neoplasms/complications , Heart Valve Diseases/complications , Stroke/etiology , Aged , Aortic Valve/diagnostic imaging , Echocardiography, Transesophageal , Fibroma/diagnostic imaging , Heart Neoplasms/diagnostic imaging , Heart Valve Diseases/diagnostic imaging , Humans , Incidental Findings , Magnetic Resonance Imaging , Male
3.
Vasc Health Risk Manag ; 4(6): 1439-47, 2008.
Article in English | MEDLINE | ID: mdl-19337557

ABSTRACT

BACKGROUND: The present study was undertaken to investigate the effect of statins plus omega-3 polyunsaturated fatty acids (PUFAs) on endothelial function and lipid profile in South Asians with dyslipidemia and endothelial dysfunction, a population at high risk for premature coronary artery disease. METHODS: Thirty subjects were randomized to rosuvastatin 10 mg and omega-3-PUFAs 4 g or rosuvastatin 10 mg. After 4 weeks, omega-3-PUFAs were removed from the first group and added to subjects in the second group. All subjects underwent baseline, 4-, and 8-week assessment of endothelial function and lipid profile. RESULTS: Compared to baseline, omega-3-PUFAs plus rosuvastatin improved endothelial-dependent vasodilation (EDV: -1.42% to 11.36%, p = 0.001), and endothelial-independent vasodilation (EIV: 3.4% to 17.37%, p = 0.002). These effects were lost when omega-3-PUFAs were removed (EDV: 11.36% to 0.59%, p = 0.003). In the second group, rosuvastatin alone failed to improve both EDV and EIV compared to baseline. However, adding omega-3-PUFAs to rosuvastatin, significantly improved EDV (-0.66% to 14.73%, p = 0.001) and EIV (11.02% to 24.5%, p = 0.001). Addition of omega-3-PUFAs further improved the lipid profile (triglycerides 139 to 91 mg/dl, p = 0.006, low-density lipoprotein cholesterol 116 to 88 mg/dl, p = 0.014). CONCLUSIONS: Combined therapy with omega-3-PUFAs and rosuvastatin improves endothelial function in South Asian subjects with dyslipidemia and endothelial dysfunction.


Subject(s)
Asian People , Dyslipidemias/drug therapy , Endothelium, Vascular/drug effects , Fatty Acids, Omega-3/therapeutic use , Fluorobenzenes/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Pyrimidines/therapeutic use , Sulfonamides/therapeutic use , Vasodilation/drug effects , Vasodilator Agents/therapeutic use , Adult , Aged , Asia/ethnology , Cross-Over Studies , Drug Therapy, Combination , Dyslipidemias/ethnology , Dyslipidemias/physiopathology , Endothelium, Vascular/physiopathology , Female , Humans , Lipids/blood , Male , Middle Aged , New York/epidemiology , Rosuvastatin Calcium , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...